Results
40
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
40 companies
Jazz Pharmaceuticals
Market Cap: US$6.7b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$108.50
7D
-2.4%
1Y
-3.9%
PharmaEssentia
Market Cap: NT$179.3b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$538.00
7D
5.9%
1Y
11.6%
ACADIA Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.71
7D
-1.2%
1Y
45.6%
Hypera
Market Cap: R$17.6b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$27.80
7D
7.0%
1Y
-3.3%
Alvotech
Market Cap: US$3.0b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$9.74
7D
-8.6%
1Y
-30.7%
Aspen Pharmacare Holdings
Market Cap: R53.0b
Manufactures and supplies specialty and branded pharmaceutical products worldwide.
APN
R119.36
7D
-1.4%
1Y
-45.8%
Organon
Market Cap: US$2.6b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$10.04
7D
5.0%
1Y
-50.8%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥18.3b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥11.31
7D
2.2%
1Y
-8.0%
Harmony Biosciences Holdings
Market Cap: US$1.9b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$32.97
7D
-7.4%
1Y
13.5%
Supernus Pharmaceuticals
Market Cap: US$1.8b
A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$32.03
7D
-3.4%
1Y
23.2%
Square Pharmaceuticals
Market Cap: ৳179.8b
Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳202.80
7D
0%
1Y
1.4%
Green Thumb Industries
Market Cap: CA$1.6b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$6.71
7D
-6.4%
1Y
-56.6%
Cosmo Pharmaceuticals
Market Cap: CHF 944.9m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 59.00
7D
-2.0%
1Y
-18.2%
Genomma Lab Internacional. de
Market Cap: Mex$20.2b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$20.68
7D
-7.2%
1Y
26.5%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥7.5b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥13.88
7D
-5.6%
1Y
18.2%
Phibro Animal Health
Market Cap: US$970.0m
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
PAHC
US$23.93
7D
-0.6%
1Y
39.0%
China Shineway Pharmaceutical Group
Market Cap: HK$6.0b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.97
7D
6.6%
1Y
-0.1%
Dong-A Socio Holdings
Market Cap: ₩769.7b
Engages in the pharmaceutical business in South Korea.
A000640
₩119,600.00
7D
5.0%
1Y
13.1%
DongKook Pharmaceutical
Market Cap: ₩769.3b
Produces and sell pharmaceutical products in South Korea and internationally.
A086450
₩17,330.00
7D
0.5%
1Y
-5.6%
Boryung
Market Cap: ₩714.5b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩8,510.00
7D
-1.6%
1Y
-17.1%
Viva Biotech Holdings
Market Cap: HK$3.8b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.79
7D
0.6%
1Y
219.6%
Boiron
Market Cap: €403.7m
Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.
BOI
€23.25
7D
1.1%
1Y
-33.0%
SIGA Technologies
Market Cap: US$460.1m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.36
7D
5.5%
1Y
-4.6%
Renata
Market Cap: ৳55.0b
Manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.
RENATA
৳479.50
7D
0%
1Y
-22.4%
JW Pharmaceutical
Market Cap: ₩542.8b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩23,400.00
7D
1.5%
1Y
-17.9%
Essex Bio-Technology
Market Cap: HK$2.9b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.09
7D
4.5%
1Y
105.2%
Beximco Pharmaceuticals
Market Cap: ৳39.0b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳87.40
7D
0%
1Y
-16.8%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.74
7D
8.3%
1Y
191.5%
Newron Pharmaceuticals
Market Cap: CHF 144.7m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 7.25
7D
-5.8%
1Y
-26.5%
Searle
Market Cap: PK₨45.9b
Manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally.
SEARL
PK₨89.83
7D
-0.7%
1Y
50.1%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م7.4b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م50.00
7D
-0.2%
1Y
37.1%
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
Market Cap: ج.م6.8b
Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.
RMDA
ج.م4.54
7D
1.3%
1Y
108.3%
Protalix BioTherapeutics
Market Cap: US$122.6m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.49
7D
-5.7%
1Y
30.7%
Unité de Fabrication des Médicaments
Market Cap: د.ت233.6m
Unité de Fabrication des Médicaments S.A.
UMED
د.ت7.30
7D
-2.0%
1Y
13.2%
Outlook Therapeutics
Market Cap: US$78.0m
Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.
OTLK
US$1.82
7D
-4.2%
1Y
-76.3%
IBN SINA Pharmaceutical Industry
Market Cap: ৳9.1b
Produces and sells pharmaceutical drugs in Bangladesh and internationally.
IBNSINA
৳291.60
7D
0%
1Y
24.5%